Tri-Heal Max Protocol (Tri-Heal Max)
High-Dose Three-Peptide Healing Blend
Community Research
Join others researching Tri-Heal Max Protocol — share findings, ask questions, and learn from real experiences
Tri-Heal Max is an enhanced healing peptide blend featuring a higher dose of TB-500 (25mg) combined with BPC-157 (10mg) and KPV (10mg) for a total of 45mg per vial. This formulation emphasizes TB-500's tissue repair and cellular migration properties, complemented by BPC-157's growth factor upregulation and KPV's anti-inflammatory effects. The higher TB-500 ratio (2.5:1:1) compared to standard healing stacks targets more significant tissue damage or accelerated recovery needs.
Each peptide contributes distinct healing pathways: TB-500 (Thymosin Beta-4) enhances cellular migration, promotes actin polymerization, and supports blood vessel formation for tissue repair; BPC-157 upregulates growth factors (VEGF, EGF), accelerates wound healing, and provides gastrointestinal protection; KPV (alpha-MSH fragment) inhibits the NF-κB inflammatory pathway, reduces pro-inflammatory cytokines, and may improve injection site tolerability. Together, they address inflammation, tissue regeneration, and cellular repair.
Molecular Data
TB-500 + BPC-157 + KPV (2.5:1:1 ratio) Complex or non-standard sequence format
Research Indications
Higher TB-500 dose targets more severe tissue damage requiring enhanced repair.
TB-500 promotes muscle fiber repair and cellular migration.
Combined collagen support and growth factor upregulation.
Multi-modal support for surgical wound recovery.
KPV component reduces post-surgical inflammatory response.
Enhanced tissue remodeling may reduce scar formation.
Accelerated return to activity after sports injuries.
Address accumulated tissue damage from repetitive stress.
Dosing Protocols
Subcutaneous injection is the primary delivery method. Can inject near injury site or systemically. The higher TB-500 content makes this suitable for more significant healing needs.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Conservative healing | 200-300mcg total blend | Once daily | SubQ |
| Standard healing protocol | 300-500mcg total blend | Once daily | SubQ |
| Intensive healing (acute injury) | 500mcg total blend | Once daily for first 2 weeks, then reduce | SubQ near injury site |
| Cycling protocol | Per standard dosing | 4-6 weeks on, 2-4 weeks off | SubQ |
Reconstitution Instructions
- Tri-Heal Max 45mg vial
- Bacteriostatic water (2-4mL)
- Insulin syringes
- Alcohol prep pads
- 1 Clean vial top with alcohol pad
- 2 Add 2mL bacteriostatic water (creates 22.5mg/mL)
- 3 Gently swirl - do not shake
- 4 Solution should appear clear
- 5 Label with date and concentration
- 6 Store refrigerated immediately
- 7 Use within 4-6 weeks
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
- Injection site reactions (KPV may help reduce these)
- Mild fatigue during healing
- Temporary redness at injection site
Stop Signs - Discontinue if:
- Severe injection site reactions or signs of infection
- Allergic reactions (rash, swelling, difficulty breathing)
- Unusual bleeding or bruising
- Worsening of underlying conditions
Contraindications
- No clinical trials on this three-peptide combination
- Active cancer (theoretical concern with growth-promoting peptides)
- Pregnancy or breastfeeding
- Active infection at injection site
Quality Checklist
Good Signs
- Third-party testing confirming all three components
- Certificate of Analysis with ratios verified
- Reputable research supplier
- Proper cold chain shipping
Warning Signs
- Research-only status - not approved for human use
- Batch variability possible in ratios
Bad Signs
- No Certificate of Analysis
- Cannot verify TB-500:BPC:KPV ratio
- Discolored or particulate solution
References
- Thymosin Beta-4 (TB-500) Tissue RepairMultiple Studies
TB-500 promotes cell migration, blood vessel formation, and wound healing through actin modulation.
- BPC-157 Healing PropertiesCurrent Pharmaceutical Design
BPC-157 upregulates growth factors and accelerates healing of various tissue types.
- KPV Anti-Inflammatory EffectsPeptide Research
KPV (alpha-MSH 11-13) inhibits NF-κB pathway and reduces pro-inflammatory cytokines.
- No Published Studies on Tri-Heal Max Combination(2024)
Specific three-peptide combination has not been studied in clinical trials.
Related Peptides
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.